FTI
EW icon

Fiduciary Trust International’s Edwards Lifesciences EW Stock Holding History

Fiduciary Trust International’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,672
Closed -$286K – 145
2019
Q4 		$286K Buy
+3,672
New +$287K 0.05% 131
2019
Q1 		– Sell
-411
Closed -$21K – 253
2018
Q4 		$21K Buy
+411
New +$20.8K 0.01% 277

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fiduciary Trust International's EW Position: Q1 2020 in Review

Fiduciary Trust International sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 3,672 shares — an estimated $286K sold.

Fiduciary Trust International first reported a position in EW in Q4 2018 and held it in 2 quarters. The position peaked at $286K in Q4 2019. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Fiduciary Trust International reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Fiduciary Trust International sold 3,672 Edwards Lifesciences shares in Q1 2020, an estimated $286K.
  • Fiduciary Trust International first reported a position in Edwards Lifesciences in Q4 2018 and held it in 2 quarters.
  • Fiduciary Trust International's Edwards Lifesciences position peaked at $286K in Q4 2019.
  • 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Fiduciary Trust International's 13F filing for Q1 2020, filed 7 May 2020.